|Podcasts|May 16, 2023
Clinical Studies Take Teamwork
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Doug Warner, MD and CMO for eFFECTOR Therapeutics, discusses the complexities of oncology clinical trials, the important relationship medical directors should have with their clinical study teams, and more.
Doug Warner, MD and CMO for eFFECTOR Therapeutics, a clinical stage biopharma targeting oncology, discusses the complexities of oncology clinical trials, bringing his career-long learnings with Amgen to his current role, and the important relationship medical directors should have with their clinical study teams.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
Operational Pragmatism in ePRO-heavy trials
3
How Selective Safety Data Collection Could Make Pragmatic Trials Scalable
4